Upstream Bio revenue was $2.37M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $613.0k, up 1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, UPB annual revenue was $2.4M, with -0.4% growth year-over-year.
UPB past revenue growth
How has UPB's revenue growth performed historically?
Upstream Bio (NASDAQ: UPB) reported Q4 2024 revenue of $613.00 thousand up 36.22% year over year. In the same quarter last year, Upstream Bio's revenue was $450.00 thousand.
What was Upstream Bio's revenue in 2024?
Upstream Bio's annual revenue for the twelve months ending Dec 31, 2024 was $2.37 million, a 0.42% decrease year over year.
How much does Upstream Bio make in a day?
Based on Upstream Bio annual revenue for the past two years, UPB makes an average of $6,506.85 per day.
What was Upstream Bio's annual revenue growth in the past year?
As of Q2 2025, Upstream Bio's revenue has grown -0.42% year over year. This is 498.11 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Upstream Bio's revenue in the past year totaled $2.37 million.
How much does Upstream Bio make in a year?
Upstream Bio's revenue by year for the past two years is:
Upstream Bio's revenue for the twelve months ending Dec 31, 2024 was $2.37 million, a 0.42% decrease year over year.
Upstream Bio's annual revenue for Dec 31, 2023 was $2.38 million, a 96.37% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.